Hepatocellular adenoma epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hepatocellular adenoma}} | {{Hepatocellular adenoma}} | ||
{{CMG}}; {{AE}}{{ | {{CMG}}; {{AE}} {{ZAS}} | ||
==Overview== | ==Overview== | ||
The hepatocellular adenoma is more common in women in western countries where they are exposed to higher doses of oral contraceptives. The estimated incidence is 3 per 1,000,000/year and is 3 to 4 per 100,000 with long term oral contraceptive use. It is more common in women of childbearing age who take oral contraceptives and can rarely occur in men who take long term anabolic androgenic steroids. | The hepatocellular adenoma is more common in women in western countries where they are exposed to higher doses of oral contraceptives. The estimated incidence is 3 per 1,000,000/year and is 3 to 4 per 100,000 with long term oral contraceptive use. It is more common in women of childbearing age who take oral contraceptives and can rarely occur in men who take long term anabolic androgenic steroids. | ||
Revision as of 15:06, 28 December 2018
|
Hepatocellular adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatocellular adenoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Hepatocellular adenoma epidemiology and demographics |
|
Hepatocellular adenoma epidemiology and demographics in the news |
|
Blogs on Hepatocellular adenoma epidemiology and demographics |
|
Risk calculators and risk factors for Hepatocellular adenoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]
Overview
The hepatocellular adenoma is more common in women in western countries where they are exposed to higher doses of oral contraceptives. The estimated incidence is 3 per 1,000,000/year and is 3 to 4 per 100,000 with long term oral contraceptive use. It is more common in women of childbearing age who take oral contraceptives and can rarely occur in men who take long term anabolic androgenic steroids.
Epidemiology and demographics
- The hepatocellular adenoma is more common in women in western countries, where they are exposed to higher doses of oral contraceptives.
- Hepatocellular adenoma is rare in regions where oral contraception is not widely used, such as asia.
- The prevalence of hepatocellular adenoma was increased in 1970s following the introduction of oral contraception in western countries.
Incidence
- The estimated incidence of hepatocellular adenoma is 3 per 1,000,000/year.[1]
- The annual incidence is substantially higher with long term oral contraceptive use, estimated at 3 to 4 per 100,000, but may be less with newer oral contraceptives.
Age
- The hepatocellular adenoma is more common in woman of childbearing age who take oral contraceptives.
Gender
- The hepatocellular adenoma is more common in women of childbearing age who take oral contraceptives, but can also occur rarely in men with long term anabolic androgenic steroids use.
References
- ↑ Barthelmes L, Tait IS (2005). "Liver cell adenoma and liver cell adenomatosis". HPB (Oxford). 7 (3): 186–96. doi:10.1080/13651820510028954. PMC 2023950. PMID 18333188.